<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04939194</url>
  </required_header>
  <id_info>
    <org_study_id>UNC , Mansoura</org_study_id>
    <nct_id>NCT04939194</nct_id>
  </id_info>
  <brief_title>Fast Track Protocol After Radical Cystectomy and Urinary Diversion: A Randomised Controlled Trial.</brief_title>
  <official_title>Fast Track Protocol After Radical Cystectomy and Urinary Diversion: A Randomised Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      We will design a randomized controlled single center study in which we will compare 2 groups&#xD;
      of patients, 1 with standard perioperative protocols and another one in which we will apply&#xD;
      fast track protocols in patients after radical cystectomy and urinary diversion .&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study hypothesis:&#xD;
&#xD;
      Fast Track Protocol after Radical Cystectomy reduces the length of hospital stay and the&#xD;
      early postoperative complications relative to the traditional perioperative care regimen.&#xD;
&#xD;
      Purpose of the study:&#xD;
&#xD;
        1. To evaluate the the perioperative efficacy, safety and benefits of fast track protocol&#xD;
           implementation after radical cystectomy and to optimize perioperative patient care for&#xD;
           the benefit of &quot;fast-track&quot; surgery.&#xD;
&#xD;
        2. To evaluate early complications in patients with bladder cancer who will be subjected to&#xD;
           radical cystectomy and urinary diversion.&#xD;
&#xD;
      Study groups:&#xD;
&#xD;
      Group 1: Fast Track group (105 patients). Group 2: Conventional perioperative care group (105&#xD;
      patients).&#xD;
&#xD;
      Study design:&#xD;
&#xD;
      The design of the research will be a prospective randomised, open-label, controlled study on&#xD;
      210 consecutive patients with bladder cancer who will be subjected to radical cystectomy and&#xD;
      urinary diversion. All the patients will sign an informed consent. Length of stay, dietary&#xD;
      issues, and return of bowel function, readmission rates and complications will be evaluated.&#xD;
&#xD;
      Study setting/location:&#xD;
&#xD;
      The study will be conducted in a single tertiary centre, Urology and Nephrology Centre in&#xD;
      Mansoura, Egypt. The study will be carried out on patient with bladder cancer who will be&#xD;
      subjected to radical cystectomy and urinary diversion.&#xD;
&#xD;
      Study duration:&#xD;
&#xD;
      The study will last about 2 and half years.&#xD;
&#xD;
      Randomisation:&#xD;
&#xD;
      Randomization will be performed using computer generated, sequentially numbered random&#xD;
      tables. Ratio of assignment to groups is 1: 1.&#xD;
&#xD;
      Allocation concealment and blinding:&#xD;
&#xD;
      We are well aware that it is very difficult to properly blind trials comparing surgical&#xD;
      treatments. Allocation of patients to treatment groups will be self-evident following&#xD;
      randomization and blinding of patient groups and observers will not be possible. So, our&#xD;
      trial will be a randomised, open-label, controlled trial.&#xD;
&#xD;
      Type of analysis:&#xD;
&#xD;
      Intention-to-treat analysis is planned in this trial. We will include all patients randomized&#xD;
      to the fast track group regardless of their adherence and compliance to the early recovery&#xD;
      after surgery (ERAS) items.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">January 15, 2021</start_date>
  <completion_date type="Anticipated">July 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2023</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Length of hospital stay.</measure>
    <time_frame>3 months after surgery.</time_frame>
    <description>Mean length of hospital stay defined as days from admission to the hospital, in both groups 1 day before surgery and discharge.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Early postoperative complications rate defined and graded according to Clavien-Dindo system.</measure>
    <time_frame>3 months after surgery.</time_frame>
    <description>Rate of early postoperative complications eg: anastomotic leakage, intestinal obstruction, wound infection.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital readmission rate.</measure>
    <time_frame>3 months after surgery.</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Bladder Cancer</condition>
  <arm_group>
    <arm_group_label>Fast Track Protocol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>the 22 items of ERAS (Early Recovery After Surgery) society</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional perioperative care program</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>standard perioperative care</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Fast Track Protocol</intervention_name>
    <description>We will apply 22 items of ERAS society</description>
    <arm_group_label>Fast Track Protocol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing radical cystectomy and urinary diversion surgery including&#xD;
             orthotopic neobladder and ileal loop conduit&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Radical cystectomy performed in an emergency setting&#xD;
&#xD;
          2. Patients who refused fast track protocol&#xD;
&#xD;
          3. Mental illnesses&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmed Mosbah, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Urology department , Urology and Nephrology Center , Faculty of Medicine, Mansoura University, Egypt</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mahmoud Laymon, Lecturer.</last_name>
    <role>Study Director</role>
    <affiliation>Urology department , Urology and Nephrology Center , Faculty of Medicine, Mansoura University, Egypt</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ahmed Lashin, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Urology department , Urology and Nephrology Center , Faculty of Medicine, Mansoura University, Egypt</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mansoura Urology &amp; Nephrology Center</name>
      <address>
        <city>Mansoura</city>
        <zip>35516</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 16, 2021</study_first_submitted>
  <study_first_submitted_qc>June 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 25, 2021</study_first_posted>
  <last_update_submitted>June 24, 2021</last_update_submitted>
  <last_update_submitted_qc>June 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Ahmed Mohammed Lashin</investigator_full_name>
    <investigator_title>A.M.Lashin</investigator_title>
  </responsible_party>
  <keyword>ERAS (Early Recovery After Surgery)</keyword>
  <keyword>Radical Cystectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Bladder Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

